Nice read, just wondering which end point your referring too ?.
I read this report that there has been improvement in early detection of MSA via PET scans, although at present imaging cannot measure NfL levels, which this paper would like too achieve with collaborative work with other stakeholders.
If they were able to detect this, and ATH434 is to show fantastic results on iron levels and NfL levels. Once a pt is scanned they go straight onto ATH434, win for all.
Ann: Alterity to Deliver Oral Presentation of ATH434 Trial at AAN, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $60.81K | 5.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 16255465 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1643984 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |